Tacrolimus
tacrolimus
102 matching records for tacrolimus.
tacrolimus
tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
tacrolimus
tacrolimus
tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus Ointment 0.1%
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
Tacrolimus
20251211
20260717
20260716
20260622
20260604
20260521
20260407
20260316
20260121
20260106
20251229
20251218
20251205
20251202
20251020
20250830
20250825
20250815
20250805
20250722
20250711
20250703
20250604
20250602
20250130
20250108
20241209
20241016
20240905
20240905
20240905
20240718
20240207
56 mapped labels
A material which is used to establish known points of reference for an assay intended to be used for the quantitative measurement and therapeutic monitoring of the immunosuppressant drug tacrolimus in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the quantitative measurement and therapeutic monitoring of the immunosuppressant drug tacrolimus in a clinical specimen, using an enzyme immunoassay (EIA) method.
A collection of reagents and other associated materials intended to be used for the quantitative measurement and therapeutic monitoring of the immunosuppressant drug tacrolimus in a clinical specimen, using a chemiluminescent immunoassay method.
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the quantitative measurement and therapeutic monitoring of the immunosuppressant drug tacrolimus in a clinical specimen.
A material which is used to verify the performance of an assay intended to be used for the quantitative measurement and therapeutic monitoring of the immunosuppressant drug tacrolimus in a clinical specimen.
A material which is used to verify the performance of an assay intended to be used for the quantitative measurement and therapeutic monitoring of multiple immunosuppressant drugs which may include cyclosporin A (or cyclosporine), tacrolimus, sirolimus and/o...
A material which is used to establish known points of reference for an assay intended to be used for the quantitative measurement and therapeutic monitoring of multiple immunosuppressant drugs which may include cyclosporin A (or cyclosporine), tacrolimus, s...
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the quantitative measurement and therapeutic monitoring of multiple immunosuppressant drugs which may include cyclosporin A (o...